Compare DAIO & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DAIO | HBIO |
|---|---|---|
| Founded | 1969 | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.9M | 26.5M |
| IPO Year | 1995 | 2000 |
| Metric | DAIO | HBIO |
|---|---|---|
| Price | $3.92 | $5.95 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | $5.22 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 144.5K | 22.8K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $21,500,000.00 | ★ $116,176,000.00 |
| Revenue This Year | $4.51 | $4.77 |
| Revenue Next Year | $30.29 | $8.55 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.16 | $0.38 |
| 52 Week High | $4.49 | $7.50 |
| Indicator | DAIO | HBIO |
|---|---|---|
| Relative Strength Index (RSI) | 59.81 | 51.66 |
| Support Level | $2.89 | $6.05 |
| Resistance Level | $4.10 | $6.79 |
| Average True Range (ATR) | 0.28 | 0.41 |
| MACD | -0.05 | -0.03 |
| Stochastic Oscillator | 68.91 | 35.13 |
Data I/O Corp provides semiconductor programming, security provisioning, and intellectual property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices and secure microcontrollers. It operates as a single segment entity, with the sole objective to design, manufacture, and sell programming solutions and Programming-as-a-Service (PaaS) to the world's various electronics manufacturers including OEMs, CMs and EMS companies. The company operate in three separate locations Redmond, Washington; Shanghai, China; and Munich, Germany.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.